|
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
PRESENTATIONS OF THE 1st AROME MEETING
| ||||
|
MEDITERRANEAN AREA CANCER EPIDEMIOLOGY
| ||||
|
1. World Cancer Epidemiology |
H. Sancho-Garnier |
|
| |
|
|
|
|
|
|
|
2. Cancer Incidence in Maghreb. North Africa |
|
M. Hamdi Cherif |
|
|
|
|
|
|
|
|
|
3. Epidemiology of Cancer in Egypt and the Arab Region |
|
T. El-Nahas |
|
|
|
|
|
|
|
|
| 4. Le probleme Cancer en France et sa Prevention |
|
H. Sancho-Garnier |
  | |
|
5. Cancer in Greece |
M. I. Koukourakis (Greece) |
| ||
| 6. Cancer and non-Surgical Cancer Treatment in Israel |
Y. Cohen (Israel) |
 | ||
| 7. Radiation Oncology in Israel |
A. Kuten (Israel) |
| ||
|
8. Epidemiology of Cancer, Registers and Inventory of Technical Plates for Management of Cancer in the Italian Area |
C. Gridelly (Italy) |
| ||
| 9. Radiotherapy in Italy |
P. Muto |
| ||
| 10. Epidemiology of Cancer in Lebanon & Radiation Oncology Facilities |
F. Geara (Lebanon) |
| ||
| 11. Institute of Radiotherapy andOncology – Skopje 2007 |
O. Arsovski (Macedonia) |
| ||
|
12. Princesse Grace Hospital, Monaco |
M. Hery (Monaco) |
| ||
| 13. Cancer Care in Morocco |
A. Benider (Morocco) |
| ||
| 14. Oncology Palestine | B. Yanes M. Jaremo A.R. Salhab (Palestinian Authority) |
| ||
| 15. Cancer Epidemiology,Registries and Inventory of Technical Structures for Cancer Care in the Mediterranean Area: in Spain (The Institut Catala d’Oncologia) |
ICO (Spain) |
| ||
|
16. Survey: Radiation Oncology in Spain |
Asumpta Company (Spain) |
| ||
| 17. Le Cancer in Syrie |
A. Al-Halabi (Syria) |
| ||
| 18. Oncology : situation in Tunisia |
N. Bouaouina (Tunisia) |
| ||
|
19. Cancer Epidemiology and Equipment Status in Turkey |
S. Turkan (Turkey) |
| ||
|
20. Former Yugoslavia |
J. Gligorov (France) |
| ||
|
INSTITUTIONAL AND GENERAL PRESENTATIONS
| ||||
|
1. e-Oncology (The Institut Catala d’Oncologia) |
ICO (Spain) |
| ||
| 2. The World Wide AROME Tool |
F. Pain (France) |
| ||
| 3. Synthesis and Proposals for the AROME Project (UICC) |
H. Sancho-Garnier (France) M. Stella de Sabata (Italy) |
| ||
| 4. Building Sustainable Cancer Control Capacity and Infrastructure in Developing Countries (IAEA) |
M. Stella de Sabata (Italy) |
| ||
|
5. Quelles Perspectives pour un Partenariat Euro-Mediterraneen (Institut de Prospective Economique Mediterraneen) |
F. Chaoui (France) |
| ||
| 6. La Complexite du traitement cancerologique |
K. Torzok (France) |
| ||
|
PHARM. INDUSTRIES AND RADIOTHERAPY EQUIPMENT
| ||||
| 1. Nucletron | A. Didier | | ||
| 2. Novartis Oncology | D. Habr | | ||
| 3. Pfizer | Dr. Mahi | | ||
| 4.Generics Will Play An Increasingly Important Role In The Pharma Industry | M. Mahjoubi | | ||
| 5. Varian | M. Baillergeau V-L. Le Glaunec |
| ||
|
| ||||
